{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:10:13Z","timestamp":1777651813227,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,8]],"date-time":"2007-12-08T00:00:00Z","timestamp":1197072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s12185-007-0015-x","type":"journal-article","created":{"date-parts":[[2008,1,15]],"date-time":"2008-01-15T05:13:39Z","timestamp":1200374019000},"page":"69-74","source":"Crossref","is-referenced-by-count":12,"title":["An autopsy case of multicentric Castleman\u2019s disease associated with interstitial nephritis and secondary AA amyloidosis"],"prefix":"10.1007","volume":"87","author":[{"given":"Yuriko","family":"Morita-Hoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Tohda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Nara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,8]]},"reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4","volume":"9","author":"B Castleman","year":"1956","unstructured":"Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956;9:822\u201330.","journal-title":"Cancer"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","volume":"86","author":"J Soulier","year":"1995","unstructured":"Soulier J, Grollet L, Oksenhendler E, et al. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease. Blood. 1995;86:1276\u201380.","journal-title":"Blood"},{"key":"15_CR3","first-page":"549","volume":"8","author":"S Tohda","year":"2001","unstructured":"Tohda S, Murakami N, Nara N. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman\u2019s disease and related diseases. Int J Mol Med. 2001;8:549\u201351.","journal-title":"Int J Mol Med"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670\u201383.","journal-title":"Cancer"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.1985.3.9.1202","volume":"3","author":"G Frizzera","year":"1985","unstructured":"Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985;3:1202\u201316.","journal-title":"J Clin Oncol"},{"key":"15_CR6","first-page":"636","volume":"20","author":"BA Peterson","year":"1993","unstructured":"Peterson BA, Frizzera G. Multicentric Castleman\u2019s disease. Semin Oncol. 1993;20:636\u201347.","journal-title":"Semin Oncol"},{"key":"15_CR7","first-page":"10","volume":"46","author":"R Bonneau","year":"1982","unstructured":"Bonneau R, Paquin F, Giroux L. Angiofollicular lymph node hyperplasia of the plasma cell type with nephrotic syndrome and systemic amyloidosis: an unusual association. Lab Invest. 1982;46:10\u20131.","journal-title":"Lab Invest"},{"key":"15_CR8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ajh.2830460306","volume":"46","author":"V Perfetti","year":"1994","unstructured":"Perfetti V, Bellotti V, Maggi A, et al. Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman\u2019s disease. Am J Hematol. 1994;46:189\u201393.","journal-title":"Am J Hematol"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000168819","volume":"15","author":"A Montoli","year":"1995","unstructured":"Montoli A, Minola E, Stabile F, et al. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman\u2019s disease). Am J Nephrol. 1995;15:142\u20136.","journal-title":"Am J Nephrol"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.7326\/0003-4819-122-5-199503010-00024","volume":"122","author":"I Kazes","year":"1995","unstructured":"Kazes I, Deray G, Jacobs C. Castleman disease and renal amyloidosis. Ann Intern Med. 1995;122:395\u20136.","journal-title":"Ann Intern Med"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000188770","volume":"71","author":"S Paydas","year":"1995","unstructured":"Paydas S, Gonlusen G, Sagliker Y. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman\u2019s disease. Nephron. 1995;71:463\u20134.","journal-title":"Nephron"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/ndt\/12.12.2713","volume":"12","author":"T Arinsoy","year":"1997","unstructured":"Arinsoy T, Yilmaz M, Ataoglu O, Bali M, Sindel S. Castleman\u2019s disease with renal amyloidosis and nephrotic syndrome. Nephrol Dial Transplant. 1997;12:2713\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0272-6386(00)70059-X","volume":"35","author":"K Keven","year":"2000","unstructured":"Keven K, Nergizoglu G, Ates K, et al. Remission of nephrotic syndrome after removal of localized Castleman\u2019s disease. Am J Kidney Dis. 2000;35:1207\u201311.","journal-title":"Am J Kidney Dis"},{"key":"15_CR14","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/ndt\/16.7.1475","volume":"16","author":"S Curioni","year":"2001","unstructured":"Curioni S, D\u2019Amico M, Quartagno R, Martino S, Dell\u2019Antonio G, Cusi D. Castleman\u2019s disease with nephrotic syndrome, amyloidosis and autoimmune manifestations. Nephrol Dial Transplant. 2001;16:1475\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00277-002-0486-z","volume":"81","author":"U Derici","year":"2002","unstructured":"Derici U, Arinsoy T, Ataoglu O, et al. Localized Castleman\u2019s disease and nephrotic syndrome not responsive to resection plus colchicine therapy. Ann Hematol. 2002;81:399\u2013401.","journal-title":"Ann Hematol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000049070","volume":"90","author":"M Mandreoli","year":"2002","unstructured":"Mandreoli M, Casanova S, Vianelli N, Pasquali S, Zucchelli P. Remission of nephrotic syndrome due to AA amyloidosis and initiation of glomerular repair after surgical resection of localized Castleman\u2019s disease. Nephron. 2002;90:336\u201340.","journal-title":"Nephron"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1440-1797.2004.00337.x","volume":"9","author":"KT Leung","year":"2004","unstructured":"Leung KT, Wong KM, Choi KS, Chau KF, Li CS. Multicentric Castleman\u2019s disease complicated by secondary renal amyloidosis. Nephrology (Carlton). 2004;9:392\u20133.","journal-title":"Nephrology (Carlton)"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00313029209063182","volume":"24","author":"KW Chan","year":"1992","unstructured":"Chan KW, Lo WK, Cheng IK. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia, and subsequent amyloidosis. Pathology. 1992;24:229\u201330.","journal-title":"Pathology"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2169\/internalmedicine.34.122","volume":"34","author":"K Tanaka","year":"1995","unstructured":"Tanaka K, Horita M, Shibayama H, et al. Secondary amyloidosis associated with Castleman\u2019s disease. Intern Med. 1995;34:122\u201326.","journal-title":"Intern Med"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000044943","volume":"78","author":"SL Lui","year":"1998","unstructured":"Lui SL, Chan KW, Li FK, Cheng IK, Chan TM. Castleman\u2019s disease and mesangial proliferative glomerulonephritis: the role of interleukin-6. Nephron. 1998;78:323\u20137.","journal-title":"Nephron"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1136\/jcp.33.11.1068","volume":"33","author":"J Diebold","year":"1980","unstructured":"Diebold J, Tulliez M, Bernadou A, et al. Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity. J Clin Pathol. 1980;33:1068\u201376.","journal-title":"J Clin Pathol"},{"key":"15_CR22","first-page":"328","volume":"49","author":"O Frokjaer Thomsen","year":"1998","unstructured":"Frokjaer Thomsen O, Ladefoged J. Castleman\u2019s disease with renal infiltration by polyclonal plasma cells. Clin Nephrol. 1998;49:328\u201330.","journal-title":"Clin Nephrol"},{"key":"15_CR23","first-page":"1322","volume":"35","author":"T Sato","year":"1994","unstructured":"Sato T, Wakabayashi Y, Hirasawa A, Tashiro Y, Nishikawa T, Chiba S. Multicentric Castleman\u2019s disease accompanied with both lymphoid interstitial pneumonia and interstitial nephritis. Rinsho Ketsueki. 1994;35:1322\u20138.","journal-title":"Rinsho Ketsueki"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jcp.36.9.1005","volume":"36","author":"GP Summerfield","year":"1983","unstructured":"Summerfield GP, Taylor W, Bellingham AJ, Goldsmith HJ. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol. 1983;36:1005\u201311.","journal-title":"J Clin Pathol"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2169\/internalmedicine.41.1158","volume":"41","author":"Q Wu","year":"2002","unstructured":"Wu Q, Jinde K, Yanagi H, Endoh M, Sakai H. Acute interstitial nephritis with polyclonal B cell infiltration and development of mantle cell lymphoma. Intern Med. 2002;41:1158\u201362.","journal-title":"Intern Med"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood.V74.4.1360.1360","volume":"74","author":"K Yoshizaki","year":"1989","unstructured":"Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6\/BSF-2) in Castleman\u2019s disease. Blood. 1989;74:1360\u20137.","journal-title":"Blood"},{"key":"15_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V95.1.56","volume":"95","author":"N Nishimoto","year":"2000","unstructured":"Nishimoto N, Sasai M, Shima Y, et al. Improvement in Castleman\u2019s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95:56\u201361.","journal-title":"Blood"},{"key":"15_CR28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archinte.1981.00340020123032","volume":"141","author":"J Garcia-SanMiguel","year":"1981","unstructured":"Garcia-SanMiguel J, Rozman C, Palacin A, Nomdedeu B. Mesenteric hyaline plasma cell lymph node hyperplasia sith amyloid deposits. Arch Intern Med. 1981;141:261\u20133.","journal-title":"Arch Intern Med"},{"key":"15_CR29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2169\/internalmedicine.34.1106","volume":"34","author":"A Miura","year":"1995","unstructured":"Miura A, Sato I, Suzuki C. Fatal diarrhea in a patient with Castleman\u2019s disease associated with intestinal amyloidosis. Intern Med. 1995;34:1106\u20139.","journal-title":"Intern Med"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00277-002-0444-9","volume":"81","author":"MR Altiparmak","year":"2002","unstructured":"Altiparmak MR, Pamuk GE, Pamuk ON, Dogusoy G. Secondary amyloidosis in Castleman\u2019s disease: review of the literature and report of a case. Ann Hematol. 2002;81:336\u20139.","journal-title":"Ann Hematol"},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/95.4.211","volume":"95","author":"HJ Lachmann","year":"2002","unstructured":"Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB. Unicentric Castleman\u2019s disease complicated by systemic AA amyloidosis: a curable disease. QJM. 2002;95:211\u20138.","journal-title":"QJM"},{"key":"15_CR32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00277-003-0718-x","volume":"82","author":"D Gholam","year":"2003","unstructured":"Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH. A case of multicentric Castleman\u2019s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol. 2003;82:766\u20138.","journal-title":"Ann Hematol"},{"key":"15_CR33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1532\/IJH97.05126","volume":"84","author":"N Yamagata","year":"2006","unstructured":"Yamagata N, Fujio J, Hirai R, et al. Marked hepatomegaly due to AA type amyloidosis in a case with Castleman\u2019s disease. Int J Hematol. 2006;84:70\u20133.","journal-title":"Int J Hematol"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00277-006-0187-0","volume":"86","author":"A Androulaki","year":"2007","unstructured":"Androulaki A, Giaslakiotis K, Giakoumi X, Aessopos A, Lazaris AC. Localized Castleman\u2019s disease associated with systemic AA amyloidosis. Regression of amyloid deposits after tumor removal. Ann Hematol. 2007;86:55\u20137.","journal-title":"Ann Hematol"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/pgmj.65.760.108","volume":"65","author":"KP West","year":"1989","unstructured":"West KP, Morgan DR, Lauder I. Angiofollicular lymph node hyperplasia with amyloidosis. Postgrad Med J. 1989;65:108\u201311.","journal-title":"Postgrad Med J"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ajcp\/78.1.112","volume":"78","author":"VA Pilon","year":"1982","unstructured":"Pilon VA, Gomez LG, Butler JJ. Systemic amyloidosis associated with a benign mesenteric lymphoid mass. Am J Clin Pathol. 1982;78:112\u20136.","journal-title":"Am J Clin Pathol"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ajcp\/94.1.101","volume":"94","author":"PA Carrington","year":"1990","unstructured":"Carrington PA, Anderson H, Harris M, Walsh SE, Houghton JB, Morgenstern GR. Autoimmune cytopenias in Castleman\u2019s disease. Am J Clin Pathol. 1990;94:101\u20134.","journal-title":"Am J Clin Pathol"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0609.2004.00302.x","volume":"73","author":"JP Quinn","year":"2004","unstructured":"Quinn JP, Gilligan OM, Horgan M. Evan\u2019s syndrome complicating multicentric Castleman\u2019s disease\u2013\u2013dramatic response to rituximab. Eur J Haematol. 2004;73:384\u20135.","journal-title":"Eur J Haematol"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","volume":"96","author":"E Oksenhendler","year":"2000","unstructured":"Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood. 2000;96:2069\u201373.","journal-title":"Blood"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-007-0015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-007-0015-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-007-0015-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T19:23:14Z","timestamp":1588274594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-007-0015-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s12185-007-0015-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,8]]}}}